KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Revenue (2016 - 2025)

LifeMD's Revenue history spans 14 years, with the latest figure at $7.1 million for Q4 2025.

  • For Q4 2025, Revenue rose 29.03% year-over-year to $7.1 million; the TTM value through Dec 2025 reached $182.0 million, up 18.5%, while the annual FY2025 figure was $194.1 million, 25.34% up from the prior year.
  • Revenue reached $7.1 million in Q4 2025 per LFMD's latest filing, down from $60.2 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $65.7 million in Q1 2025 to a low of $5.5 million in Q4 2024.
  • Average Revenue over 5 years is $35.0 million, with a median of $32.3 million recorded in 2022.
  • Peak YoY movement for Revenue: soared 322.74% in 2021, then plummeted 87.77% in 2024.
  • A 5-year view of Revenue shows it stood at $27.4 million in 2021, then rose by 2.56% to $28.1 million in 2022, then soared by 59.53% to $44.9 million in 2023, then tumbled by 87.77% to $5.5 million in 2024, then increased by 29.03% to $7.1 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Revenue are $7.1 million (Q4 2025), $60.2 million (Q3 2025), and $49.0 million (Q2 2025).